At home, K-convenience stores battle stagnation; abroad they're powerful K-food ambassadors

In the bustling backstreets of Ulaanbaatar, shoppers file out of a CU convenience store with instant tteokbokki, or simmered Korean rice cake, packs...

Organic food chain Chorocmaeul up for sale amid liquidity woes

Financial investors in Chorocmaeul Co., a South Korean organic food store chain, are seeking to sell the management control of the company, which re...

Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma

BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...

President Lee: Businesses at center of policy priorities for economic growth

South Korean President Lee Jae-myung on Friday pledged strong government support for the country’s businesses, while emphasizing the need for ...

S.Korea’s No.1 dried seaweed firm Kwangcheonkim on market for $295 mn

Kwangcheonkim Co., South Korea’s largest seaweed producer with a history spanning over 50 years, is up for grabs in a deal that could fetch up...

Jollibee to buy chicken chain Norang Tongdak amid global K-food frenzy

Jollibee Foods Corp., a household name in Southeast Asia’s food market, has been named the preferred buyer of Norang Tongdak, a South Korean f...

Markets in honeymoon with Lee: Kospi, won rally; bond yields spike

South Korea’s financial markets showed strong gains on Thursday, with shares surging to an 11-month high and the won hitting a seven-month hig...

Ramen, ready-to-eat meals lead 10% rise in 2024 K-food exports

South Korea’s food exports climbed 10% on-year to $7.26 billion in 2024, led by ramen, ready-to-eat meals and seasoned seaweed, according to g...

Bold food tech R&D fuels global rise of Korean cuisine

South Korea’s processed food exports are expected to reach 6 trillion won ($4.4 billion) this year after Korean food companies have aggressive...

US considers withdrawing thousands of troops from South Korea

.video-container { position: relative; padding-bottom: 56.25%; padding-top: 30px; height: 0; overflow: hidden; } .video-container ifr...

Samsung Biologics to spin off biosimilar unit Samsung Bioepis

Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufac...

Hanwha Philly Shipyard to localize LNG builds, expand capacity

Hanwha Group will significantly increase production capacity at its US shipyard from 1.5 vessels to 10 per year as it aims to transform the facility...

Hyundai Rotem lands $301 mn Taiwan driverless train deal

Hyundai Rotem Co. has won a 420 billion won ($301 million) order to build autonomous electric trains for Taiwan’s Taichung Metro, adding to a ...

Hanwha acquires Ourhome for $622 million in push to revive food business

South Korea’s Hanwha Group has completed the acquisition of the country’s No. 2 food service and catering company Ourhome Ltd. for 869.5...

Shinsegae Chair Chung joins Trump’s Middle East tour

Chung Yong-jin, chairman of South Korea’s retail group Shinsegae Inc., is the only Korean businessperson accompanying US President Donald Trum...

South Korea asks US for tailored approach to chip tariffs

South Korea has officially requested that the US take a distinct approach in its ongoing probe into foreign semiconductor technology and related dow...

Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Seoul mulls joint review of Alaska LNG project with Japan, Taiwan, Vietnam

South Korea has proposed forming a consortium with Japan, Taiwan and Vietnam to jointly assess the feasibility of investing in the $45 billion Alask...

S.Korea plans $1.2 bn forex bond issue after presidential election

South Korea plans to issue up to $1.2 billion in foreign exchange stabilization bonds as early as June, in what would mark the new administration&rs...

India: Tantalizing frontier for K-food’s global ambitions beyond China

South Korea’s processed food exports to India have surged to a record 6 trillion won ($4.1 billion), marking a significant milestone in the gr...

Celltrion expands footprint in Latin America with flagship oncology drugs

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

SK chairman in Taiwan to deepen ties with TSMC

Chey Tae-won, chairman of SK Group, the parent of SK Hynix Inc., is visiting Taiwan amid the threat of escalating US tariff threats, suggesting the ...

Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

KFC’s Korean operations up for sale

Orchestra Private Equity has begun the process of divesting the South Korean operations of fast-food chain KFC, which has seen earnings growth since...

Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

Baemin, Yogiyo see record transaction drops in Feb amid Coupang's rise

South Korea’s top and third-ranked food delivery apps, Baedal Minjok (Baemin) and Yogiyo, saw their biggest-ever monthly drops in transaction ...

SillaJen: First to use lab-grown human tissue to find best cancer drug dose

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...

Chong Kun Dang to build new plant for foray into biologics market

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Coupang posts profit for 2 straight years in 2024 on new growth drivers

Coupang Inc., South Korea’s answer to global e-commerce giant Amazon.com, ended last year with profit for the second straight year thanks to t...

Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...